EP0770086A4 - Macrophage migration inhibitory factor-3 - Google Patents

Macrophage migration inhibitory factor-3

Info

Publication number
EP0770086A4
EP0770086A4 EP94923875A EP94923875A EP0770086A4 EP 0770086 A4 EP0770086 A4 EP 0770086A4 EP 94923875 A EP94923875 A EP 94923875A EP 94923875 A EP94923875 A EP 94923875A EP 0770086 A4 EP0770086 A4 EP 0770086A4
Authority
EP
European Patent Office
Prior art keywords
inhibitory factor
macrophage migration
migration inhibitory
macrophage
factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP94923875A
Other languages
German (de)
French (fr)
Other versions
EP0770086A1 (en
Inventor
Haodong L
Lisa M Fitzgerald
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of EP0770086A1 publication Critical patent/EP0770086A1/en
Publication of EP0770086A4 publication Critical patent/EP0770086A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EP94923875A 1994-05-16 1994-05-16 Macrophage migration inhibitory factor-3 Withdrawn EP0770086A4 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1994/005385 WO1995031468A1 (en) 1994-05-16 1994-05-16 Macrophage migration inhibitory factor-3

Publications (2)

Publication Number Publication Date
EP0770086A1 EP0770086A1 (en) 1997-05-02
EP0770086A4 true EP0770086A4 (en) 1998-07-15

Family

ID=22242566

Family Applications (1)

Application Number Title Priority Date Filing Date
EP94923875A Withdrawn EP0770086A4 (en) 1994-05-16 1994-05-16 Macrophage migration inhibitory factor-3

Country Status (4)

Country Link
EP (1) EP0770086A4 (en)
JP (1) JPH10500301A (en)
AU (1) AU7394294A (en)
WO (1) WO1995031468A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458349B1 (en) 1995-06-02 2002-10-01 Human Genome Sciences, Inc. Chemokine β-4 polypeptides
US6174995B1 (en) 1994-08-23 2001-01-16 Haodong Li Human chemokines, CKβ4 and CKβ10/MCP-4
US6391589B1 (en) 1994-08-23 2002-05-21 Human Genome Sciences, Inc. Human chemokine beta-10 mutant polypeptides
US6290948B1 (en) 1996-05-14 2001-09-18 Smithkline Beecham Corporation Method of treating sepsis and ARDS using chamohine beta-10
US6812327B1 (en) 1996-10-25 2004-11-02 Human Genome Sciences, Inc. Neutrokine-alpha polypeptides
US8212004B2 (en) 1999-03-02 2012-07-03 Human Genome Sciences, Inc. Neutrokine-alpha fusion proteins
US7879328B2 (en) 2000-06-16 2011-02-01 Human Genome Sciences, Inc. Antibodies that immunospecifically bind to B lymphocyte stimulator
CA2407910C (en) 2000-06-16 2013-03-12 Steven M. Ruben Antibodies that immunospecifically bind to blys
US20030091565A1 (en) 2000-08-18 2003-05-15 Beltzer James P. Binding polypeptides and methods based thereon
WO2002020758A2 (en) * 2000-09-05 2002-03-14 Curagen Corporation Novel proteins and nucleic acids encoding same
ATE518884T1 (en) 2002-05-01 2011-08-15 Human Genome Sciences Inc ANTIBODIES SPECIFICALLY BINDING TO CHEMOKIN BETA-4
US9168286B2 (en) 2005-10-13 2015-10-27 Human Genome Sciences, Inc. Methods and compositions for use in treatment of patients with autoantibody positive disease
WO2007123765A2 (en) 2006-03-31 2007-11-01 Human Genome Sciences Inc. Neutrokine-alpha and neutrokine-alpha splice variant
KR101919170B1 (en) 2010-11-19 2018-11-15 에자이 알앤드디 매니지먼트 가부시키가이샤 Neutralizing anti-ccl20 antibodies
AU2012320597C1 (en) 2011-10-07 2015-10-15 Baxalta GmbH oxMIF as a diagnostic marker
WO2013184209A1 (en) * 2012-06-04 2013-12-12 Ludwig Institute For Cancer Research Ltd. Mif for use in methods of treating subjects with a neurodegenerative disorder

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
S. HIROSE ET AL.: "Macrophage Migration Inhibitory Factor {MIF} produced by a human T cell hybridoma clone", MICROBIOLOGY AND IMMUNOLOGY, vol. 35, no. 3, 1991, pages 235 - 245, XP000672573 *
See also references of WO9531468A1 *

Also Published As

Publication number Publication date
WO1995031468A1 (en) 1995-11-23
JPH10500301A (en) 1998-01-13
AU7394294A (en) 1995-12-05
EP0770086A1 (en) 1997-05-02

Similar Documents

Publication Publication Date Title
SG46750A1 (en) Resistance thermometer
EP0770086A4 (en) Macrophage migration inhibitory factor-3
GB2290823B (en) Multiple glazing unit
GB2292581B (en) Multiple glazing units
GB2295534B (en) Scraper
ZA943698B (en) Macrophage migration inhibitorz factor-3
GB9516070D0 (en) Partition
SG45129A1 (en) Structural element
GB9522355D0 (en) Rack
GB9425257D0 (en) Variable resistance sensors
GB9411901D0 (en) Racks
AU545P (en) WAKEFIELD Microlaena stipoides
IL111179A0 (en) Thermometer
EG20561A (en) Oxadiazine derivatives
ZA95444B (en) Macrophage nucleotide sequence
GB9423284D0 (en) Rack
AU124123S (en) Rack
PL101619U1 (en) Buily-up rack
KR950028498U (en) Rack
AU124978S (en) Extrusion
AU121183S (en) Extrusion
AU122096S (en) Extrusion
AU122097S (en) Extrusion
AU122098S (en) Extrusion
AU123421S (en) Extrusion

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19961212

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): BE CH DE FR GB IT LI NL

RHK1 Main classification (correction)

Ipc: C12N 15/00

A4 Supplementary search report drawn up and despatched

Effective date: 19980602

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): BE CH DE FR GB IT LI NL

17Q First examination report despatched

Effective date: 19991102

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20000613